Cantú G, Rodríguez G, Luque-Coqui M, Romero B, Valverde S, Vargas S, Reyes-López A, Medeiros M

Language: Spanish
References: 22
Page: 290-294
PDF size: 86.63 Kb.

ABSTRACT

Background. Chronic renal disease (CRD) is a disease with a strong impact on the childhood Mexican population with short-range limiting and serious consequences. Poverty and a social environment devoid of social justice hinder timely medical attention and long-range rehabilitation. The aim of this study was to determine the differences regarding sociodemographic features in patients under treatment at Hospital Infantil de México Federico Gómez, with a 6-year difference: patients diagnosed in 2003 as compared to those diagnosed in 2009.
Methods. A retrospective comparative study was carried out with end-stage chronic renal disease (ESRD) patients with information obtained from the clinical files. Data were obtained on age, gender, renal insufficiency etiology, socioeconomic level, type of financing, place of origin, and whether patient entered a rehabilitation program (dialysis or transplant).
Results. In 2003, 69 patients with ESRD were received, whereas 50 patients were received in 2009. There were no differences in age or gender between dates. Etiology of uremia was determined in 40% of the children in 2003 and 50% in 2009. Most patients in the assessed years belong to the lowest socioeconomic levels, coming from the State of Mexico and metropolitan Mexico City. There was a decreasing trend in the number of patients coming from other states of the country: 30% in 2003 and 16% in 2009. Twenty-three patients (33%) entered the rehabilitation program in 2003 and 29 patients (58%) in 2009 (p = 0.007).
Conclusions. There was a 28% decrease between 2003 and 2009 in the number of cases being managed. Attention has been focused on the State of Mexico and metropolitan Mexico City area. In spite of socioeconomic level being apparently similar in the studied years, there was a significant increase in the proportion of children entering a long-range rehabilitation program (from 33% in 2003 to 58% in 2009).

REFERENCES

1. Medeiros M, Muñoz-Arizpe R. Enfermedad renal en niños. Un problema de salud pública. Bol Med Hosp Infant Mex 2011;68:259-261.

2. López-Cervantes M, Rojas-Russell M, Tirado-Gómez LL, Durán-Arenas L, Pacheco-Domínguez RL, Venado-Estrada AA, et al. Enfermedad renal crónica y su atención mediante tratamiento sustitutivo en México. Facultad de Medicina, Universidad Nacional Autónoma de México, México D.F. México; 2009.

3. Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, et al. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 2003;111:1416-1421.

4. Klarenbach S, Manns B. Economic evaluation of dialysis therapies. Semin Nephrol 2009;29:524-532.

5. Harambat J, van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol 2012;27:363-373.

6. Warady BA, Chadha V. Chronic kidney disease in children: the global perspective. Pediatr Nephrol 2007;22:1999-2009.

7. Ardissino G, Dacco V, Testa S, Bonaudo R, Claris--Appiani A, Taioli E, et al. Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics 2003;111:e382-e387.

8. Obrador GT, García-García G, Villa AR, Rubilar X, Olvera N, Ferreira E, et al. Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) México and comparison with KEEP US. Kidney Int Suppl 2010:S2-S8.

9. Medeiros-Domingo M, Romero-Navarro B, Valverde-Rosas S, Delgadillo R, Varela-Fascinetto G, Muñoz-Arizpe R. [Renal transplantation in children]. Rev Invest Clin 2005;57:230-236.

10. Beauchamp TL. Methods and principles in biomedical ethics. J Med Ethics 2003;29:269-274.

11. Buchanan A. A health-care delivery and resource allocation. En: Veatch RM, ed. Medical Ethics. Boston: Jones and Bartlett Publishers; 1997. pp. 321-358.

12. Sakhuja V, Sud K. End-stage renal disease in India and Pakistan: burden of disease and management issues. Kidney Int Suppl 2003:S115-S118.

13. Yeates K. Health disparities in renal disease in Canada. Semin Nephrol 2010;30:12-18.

14. Xue JL, Eggers PW, Agodoa LY, Foley RN, Collins AJ. Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries. J Am Soc Nephrol 2007;18:1299-1306.

15. Franco-Marina F, Tirado-Gómez LL, Venado-Estrada A, Moreno-López JA, Pacheco-Domínguez RL, Durán-Arenas L, et al. Una estimación indirecta de las desigualdades actuales y futuras de la frecuencia de enfermedad renal crónica terminal en México. Salud Publica Mex 2011;53(suppl 4):506-515.

16. García-García G, Renoirte-López K, Márquez-Magaña I. Disparities in renal care in Jalisco, Mexico. Semin Nephrol 2010;30:3-7.

17. Cantú-Quintanilla G, Orta-Sibú N, Romero-Navarro B, Luque-Coqui M, Medeiros-Domingo M, Grimoldi I, et al. Patrones de suficiencia y prioridad de la justicia distributiva en atención de los pacientes pediátricos con enfermedad renal crónica terminal en América Latina y el Caribe. Arch Latin Nefr Ped 2010;10:25-33.

18. Cantú-Quintanilla G, Orta-Sibu N, Romero-Navarro B, Luque-Coqui M, Rodríguez-Ortega EG, Reyes-López A, et al. Acceso a trasplante renal de donante fallecido en pacientes pediátricos de América Latina y el Caribe. Pers Bioét 2010;14:151-162.

19. Staples A, Wong C. Risk factors for progression of chronic kidney disease. Curr Opin Pediatr 2010;22:161-169.

20. Whaley-Connell AT, Vassalotti JA, Collins AJ, Chen SC, McCullough PA. National Kidney Foundation's Kidney Early Evaluation Program (KEEP) annual data report 2011: executive summary. Am J Kidney Dis 2012;59(suppl 2):S1-S4.

21. Obrador GT, Mahdavi-Mazdeh M, Collins AJ; Global Kidney Disease Prevention Network. Establishing the Global Kidney Disease Prevention Network (KDPN): a position statement from the National Kidney Foundation. Am J Kidney Dis 2011;57:361-370.

22. Garcia GG, Harden P, Chapman J; for the World Kidney Day Steering Committee. The global role of kidney transplantation. Transplantation 2012;93:337-341.